{{Short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 462265582
| IUPAC_name = 1-Cyclopropyl-7-[(3''s'',5''r'')-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
| image = orbifloxacin.png

<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|international|orbifloxacin}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status = veterinary use only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 113617-63-3
| ATCvet = yes
| ATC_prefix = J01
| ATC_suffix = MA95
| PubChem = 60605
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 54631
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 660932TPY6
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08299
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 295433

<!--Chemical data-->
| C=19 | H=20 | F=3 | N=3 | O=3
| smiles = O=C(O)C1=CN(C2CC2)c3c(C1=O)c(F)c(F)c(c3F)N4C[C@H](C)N[C@H](C)C4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H20F3N3O3/c1-8-5-24(6-9(2)23-8)17-14(21)13(20)12-16(15(17)22)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6H2,1-2H3,(H,27,28)/t8-,9+
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QIPQASLPWJVQMH-DTORHVGOSA-N
}}

'''Orbifloxacin''' (brand name '''Orbax''') is a [[fluoroquinolone]] [[antibiotic]] which is approved for use in dogs,<ref>{{cite web | url = http://dil.vetmed.vt.edu/Display/NadaBrowse.cfm?NadaString=141-081 | title = Product Abstract - NADA 141-081 | access-date = 21 June 2008 | publisher = American College of Veterinary Clinical Pharmacology | url-status =  }}{{deadlink|date=September 2023}}</ref><ref>{{cite book | vauthors = Papich MG | chapter = Orbifloxacin | chapter-url = https://books.google.com/books?id=MVcBEAAAQBAJ&pg=PA674 | page = 674 | title=Papich Handbook of Veterinary Drugs |date= October 2020 |location=St. Louis, Missouri | publisher = Elsevier Health Sciences |isbn=978-0-323-70958-3 |edition=Fifth}}</ref> marketed by [[Schering-Plough|Schering-Plough Animal Health]].

==See also==
[[File:Orbax.jpg|thumb|Orbax medication]]
* [[Quinolone antibiotic|Quinolone]]

==References==
{{Reflist}}

{{QuinoloneAntiBiotics}}

[[Category:Fluoroquinolone antibiotics]]
[[Category:Cyclopropanes]]
[[Category:Dog medications]]
[[Category:1,4-di-hydro-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic acids]]


{{antibiotic-stub}}
{{Veterinary-med-stub}}